[Treatment of infants with Pierre Robin syndrome using the orthodontic device PEBP (pre-epiglottic baton plate)]. / Lechenie mladentsev s sindromom P'era Robena s primeneniem ortodonticheskogo apparata PEBP (pre-epiglottic baton plate).

OBJECTIVE: To evaluate the effectiveness of the method of treatment of Pierre Robin syndrome using the orthodontic device PEBP (pre-epiglottic baton plate). MATERIALS AND METHODS: The study involved 5 patients with moderate SPD aged 1 to 3 months. All patients showed signs of respiratory failure and impaired swallowing. Respiratory failure was assessed based on oxygen concentration by pulse oximetry, respiratory rate (BPD), and skin color. Swallowing was evaluated for the possibility of taking food through the mouth and refusing a nasogastric tube. To eliminate violations, the orthodontic device PEBP was used, which was made in the dental laboratory from plastic and metal ligatures. RESULTS: Against the background of treatment with an orthodontic device, there was an increase in blood oxygen levels, a decrease in BPD, and normalization of skin color. In all patients, in the first two days from the start of treatment, nutrition was restored through the oral cavity and the ability to refuse nutrition through a nasogastric tube. CONCLUSIONS: The use of the PEBP orthodontic device makes it possible to effectively eliminate respiratory and nutritional disorders in the first months in patients with SPD.

[Effect of a gel based on recombinant human angiogenin on the healing of donor palate wounds]. / Vliianie gelia na osnove rekombinantnogo angiogenina cheloveka na zazhivlenie donorskikh ran tverdogo neba.

The aim of the study was to study the effect of the gel on the basis of recombinant human angiogenin on the rate of regeneration of donor palatal wounds. The study involved 20 patients (8 men and 12 women) aged 32 to 55 years. Patients were divided into two groups: the 1st group is a study group (n=10), whose patients in the postoperative period used a gel based on recombinant human angiogenin, the 2nd group is a control group (n=10) in which a gel based on recombinant human angiogenin was not used. Patients in both study groups underwent vestibuloplasty with simultaneous plasty of the attached keratinized gingiva with a free gingival graft from the area of the hard palate. The operations were carried out at the stage of disclosing dental implants, simultaneously with the installation of healing abatements or 4 weeks before dental implantation. For histological examination, tissue samples were obtained from the region of the edge of the donor's wounds of the palate at the 7th and 14th days after surgery. As a result of the study, significant differences were found in the comparison groups when assessing the processes of inflammation, angiogenesis and epithelization. The local application of the gel containing recombinant human angiogenin resulted in a rapid decrease in the intensity of inflammation in lamina propria mucosae and a significant decrease in the bulk density of cell infiltrates, accelerating regeneration. This is primarily due to the stimulation of the development of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and increased blood supply to the affected area, as well as an increase in the proportion of fibroblasts. The most important observation was the increase in the rate of epithelialization of donor wounds of the hard palate.